The phytoestrogen genistein is a tissue-specific androgen receptor modulator

Endocrinology

Volumn 152, Issue 11, 2011, Pages 4395-4405

  Pihlajamaa, Päivi ^a   Zhang, Fu Ping ^a   Saarinen, Lilli ^a   Mikkonen, Laura ^b   Hautaniemi, Sampsa ^a   Jänne, Olli A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; LUCIFERASE; PROTEIN; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SEX LIMITED PROTEIN; TESTOSTERONE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANDROGEN THERAPY; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; GENOME; IN VIVO STUDY; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; REPORTER GENE; RISK REDUCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TESTIS;

ANIMALS; BRAIN; FEMALE; GENE EXPRESSION; GENES, REPORTER; GENISTEIN; MALE; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PHYTOESTROGENS; PROMOTER REGIONS, GENETIC; PROSTATE; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TESTIS;

EID: 80054931337     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0221     Document Type: Article

References (51)

1. Ma RW, Chapman K 2009 A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet 22: 187-199
2. Ferlay J, Bray F, Pisani P, Parkin DM 2004 GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide IARC Cancer Base no. 5. version 2.0. Lyon, France: International Agency for Research on Cancer Press
3. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM 1991 Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Br J Cancer 63:963-966
4. Pandjaitan N, Hettiarachchy N, Ju ZY, Crandall P, Sneller C, Dombek D 2000 Evaluation of genistin and genistein contents in soybean varieties and soy protein concentrate prepared with 3 basic methods. J Food Sci 65:399-402 (Pubitemid 30410918)
5. Yan L, Spitznagel EL 2009 Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89:1155-1163
6. Jian L 2009 Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 53:217-226
7. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH 2005 Inactivation of nuclear factor κB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 65:6934-6342
8. Kousidou OC, Mitropoulou TN, Roussidis AE, Kletsas D, Theocharis AD, Karamanos NK 2005 Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int J Oncol 26:1101-1109
9. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y 1987 Genistein, a specific inhibitor of tyrosine- specific protein kinases. J Biol Chem 262:5592-5595
10. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC 2008 Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68:2024-2032 (Pubitemid 351416590)
11. Wang J, Eltoum IE, Lamartiniere CA 2007 Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog 6:3
12. Heemers HV, Tindall DJ 2007 Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28:778-808 (Pubitemid 350294296)
13. Adler AJ, Scheller A, Robins DM 1993 The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences. Mol Cell Biol 13:6326-6335 (Pubitemid 23292626)
14. Verrijdt G, Schoenmakers E, Haelens A, Peeters B, Verhoeven G, Rombauts W, Claessens F 2000 Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J Biol Chem 275: 12298-12305 (Pubitemid 30237811)
15. Verrijdt G, Schauwaers K, Haelens A, Rombauts W, Claessens F 2002 Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer. J BiolChem277:35191-35201
16. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, Lowik C, Maggi A 2003 In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9:82-86 (Pubitemid 36098264)
17. Lemmen JG, Arends RJ, van Boxtel AL, van der Saag PT, van der Burg B 2004 Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice. J Mol Endocrinol 32:689-701 (Pubitemid 38877682)
18. Ramachandran B, Mäkelä S, Cravedi JP, Berglund M, Håkansson H, Damdimopoulou P, Maggi A 2011 Estrogen-like effects of diet-derived cadmium differ from those of orally administered CdCl(2) in the ERE-luc estrogen reporter mouse model. Toxicol Lett 202:75-84
19. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, van der Saag P, Pettersson K, Gauglitz G, Mäkelä S, Pongratz I 2007 Diet- derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148:4875-4886 (Pubitemid 47481543)
20. Phi-Van L, von Kries JP, Ostertag W, Strätling WH 1990 The chicken lysozyme 5′ matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. Mol Cell Biol 10:2302-2307
21. Pajunen AE, Isomaa VV, Jänne OA, Bardin CW 1982 Androgenic regulation of ornithine decarboxylase activity in mouse kidney and its relationship to changes in cytosol and nuclear androgen receptor concentrations. J Biol Chem 257:8190-8198 (Pubitemid 13241237)
22. Kontula KK, Torkkeli TK, Bardin CW, Jänne OA 1984 Androgen induction of ornithine decarboxylase mRNA in mouse kidney as studied by complementary DNA. Proc Natl Acad Sci USA 81: 731-735 (Pubitemid 14199020)
23. Melanitou E, Cohn DA, Bardin CW, Jänne OA 1987 Genetic variation in androgen regulation of ornithine decarboxylase gene expression in inbred strains of mice. Mol Endocrinol 1:266-273
24. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomäki V, Valo E, Núñez-Fontarnau J, Rantanen V, Karinen S, Nousiainen K, Lahesmaa-Korpinen AM, Miettinen M, Saarinen L, Kohonen P, Wu J, Westermarck J, Hautaniemi S 2010 Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med 2:65
25. Mikkonen L, Pihlajamaa P, Sahu B, Zhang FP, Jänne OA 2010 Androgen receptor function in lung. Mol Cell Endocrinol 317: 14-24
26. Basak S, Pookot D, Noonan EJ, Dahiya R 2008 Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function. Mol Cancer Ther 7:3195-3202
27. Hong EJ, Sahu B, Jänne OA, Hammond GL 2011 Cytoplasmic accumulation of incompletely glycosylated SHBG enhances androgen action in proximal tubule epithelial cells. Mol Endocrinol 25:269-281
28. Ottobrini L, Ciana P, Biserni A, Lucignani G, Maggi A 2006 Molecular imaging: anewwayto study molecular processes in vivo.Mol Cell Endocrinol 246:69-75 (Pubitemid 43238399)
29. Lyons SK, Lim E, Clermont AO, Dusich J, Zhu L, Campbell KD, Coffee RJ, Grass DS, Hunter J, Purchio T, Jenkins D 2006 Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice. Cancer Res 66:4701-4707
30. Iyer M, Salazar FB, Lewis X, Zhang L, Wu L, Carey M, Gambhir SS 2005 Noninvasive imaging of a transgenic mouse model using prostate- specific two-step transcriptional amplification strategy. Transgenic Res 14:47-55 (Pubitemid 40374667)
31. Hsieh CL, Xie Z, Liu ZY, Green JE, Martin WD, Datta MW, Yeung F, Pan D, Chung LW 2005 A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals. J Mol Endocrinol 35:293-304 (Pubitemid 41556177)
32. Xie X, Luo Z, Slawin KM, Spencer DM 2004 The EZC-prostate model: noninvasive prostate imaging in living mice. Mol Endocrinol 18:722-73233.
33. Ellwood-Yen K, Wongvipat J, Sawyers C 2006 Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens. Cancer Res 66:10513-10516
34. Ye X, Han SJ, Tsai SY, DeMayo FJ, Xu J, Tsai MJ, O'Malley BW 2005 Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc Natl Acad Sci USA 102:9487-9492 (Pubitemid 40981708)
35. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC 2009 Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30:293-342
36. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson J-Å 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263 (Pubitemid 28513713)
37. Jefferson WN, Padilla-Banks E, Newbold RR 2007 Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol 23:308-316 (Pubitemid 46628872)
38. Barnes S, Peterson TG, Coward L 1995 Rationale for the use of genistein- containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 22:181-187
39. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE 1998 Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68(Suppl 6):1453S-1461S (Pubitemid 28550929)
40. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE 1997 Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350:23-27
41. Jefferson WN, Williams CJ 2011 Circulating levels of genistein in the neonate, apart from dose and route, predict future adverse female reproductive outcomes. Reprod Toxicol 31:272-279
42. Doerge DR, Twaddle NC, Banks EP, Jefferson WN, Newbold RR 2002 Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice. Cancer Lett 184:21-27 (Pubitemid 34718103)
43. Nishizaki Y, Ishimoto Y, Hotta Y, Hosoda A, Yoshikawa H, Akamatsu M, Tamura H 2009 Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay. Bioorg Med Chem Lett 19:4706-4710
44. Reinikainen P, Palvimo JJ, Jänne OA 1996 Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137: 4351-4357 (Pubitemid 26321884)
45. Lavigne JA, Takahashi Y, Chandramouli GV, Liu H, Perkins SN, Hursting SD, Wang TT 2008 Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study. Breast Cancer Res Treat 110:85-98 (Pubitemid 351793861)
46. Evans BA, Griffiths K, Morton MS 1995 Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147:295-302
47. Haendler B, Cleve A 16 June 2011 Recent developments in antiandrogens and selective androgen receptor modulators. Mol Cell Endocrinol 10.1016/j.m.e. 2011.06.002
48. Wang H, Li J, Gao Y, Xu Y, Pan Y, Tsuji I, Sun ZJ, Li XM 2010 Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor. Asian J Androl 12:535-547
49. Bovee TF, Schoonen WG, Hamers AR, Bento MJ, Peijnenburg AA 2008 Screening of synthetic and plant-derived compounds for (anti) estrogenic and (anti)androgenic activities. Anal Bioanal Chem 390:1111-1119
50. Takeuchi S, Takahashi T, Sawada Y, Iida M, Matsuda T, Kojima H 2009 Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol Pharm Bull 32:195-202
51. Takahashi Y, Lavigne JA, Hursting SD, Chandramouli GV, Perkins SN, Barrett JC, Wang TT 2004 Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: identification of novel targets. Mol Carcinog 41:108-119 (Pubitemid 39336760)